These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26456227)

  • 1. Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample.
    Cawley AT; Smart C; Greer C; Liu Lau M; Keledjian J
    Drug Test Anal; 2016 Feb; 8(2):257-61. PubMed ID: 26456227
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.
    Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D
    Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
    Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample.
    Starcevic B; Ahrens BD; Butch AW
    Drug Test Anal; 2013 May; 5(5):377-9. PubMed ID: 23427117
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Rapid Commun Mass Spectrom; 2016 Apr; 30(7):833-42. PubMed ID: 26969924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine in vivo metabolite profiling of the selective androgen receptor modulator LGD-3303 for doping control.
    Broberg MN; Knych H; Bondesson U; Pettersson C; Tidstedt B; Stanley S; Thevis M; Hedeland M
    J Pharm Biomed Anal; 2023 Sep; 233():115468. PubMed ID: 37224728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing.
    Thevis M; Lohmann W; Schrader Y; Kohler M; Bornatsch W; Karst U; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):163-70. PubMed ID: 18708696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and confirmation of 60 anabolic and androgenic steroids in equine plasma by liquid chromatography-tandem mass spectrometry with instant library searching.
    Liu Y; Uboh CE; Soma LR; Li X; Guan F; You Y; Rudy JA; Chen JW
    Drug Test Anal; 2011 Jan; 3(1):54-67. PubMed ID: 20878876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of 19-nortestosterone and its esters in equine plasma by high-performance liquid chromatography with tandem mass spectrometry.
    Kim JY; Choi MH; Kim SJ; Chung BC
    Rapid Commun Mass Spectrom; 2000; 14(19):1835-40. PubMed ID: 11006593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
    Thevis M; Geyer H; Kamber M; Schänzer W
    Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput UHPLC-MS/MS method for the detection, quantification and identification of fifty-five anabolic and androgenic steroids in equine plasma.
    Guan F; Uboh CE; Soma LR; You Y; Liu Y; Li X
    J Mass Spectrom; 2010 Nov; 45(11):1270-9. PubMed ID: 20872903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a multi-residue high-throughput UHPLC-MS/MS method for routine monitoring of SARM compounds in equine and bovine blood.
    Ventura E; Gadaj A; Buckley T; Mooney MH
    Drug Test Anal; 2020 Sep; 12(9):1373-1379. PubMed ID: 32519780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes.
    Cutler C; Viljanto M; Taylor P; Hincks P; Biddle S; Van Eenoo P
    Drug Test Anal; 2022 Feb; 14(2):349-370. PubMed ID: 34714606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of selective androgen receptor modulator YK-11 in a doping control sample.
    Sobolevsky T; Kucherova Y; Ahrens B
    Drug Test Anal; 2024 Jun; 16(6):655-660. PubMed ID: 37946705
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
    Gao W; Reiser PJ; Coss CC; Phelps MA; Kearbey JD; Miller DD; Dalton JT
    Endocrinology; 2005 Nov; 146(11):4887-97. PubMed ID: 16099859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry.
    Guan F; Uboh CE; Soma LR; Luo Y; Rudy J; Tobin T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):56-68. PubMed ID: 16289956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes.
    Thevis M; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2006; 20(5):870-6. PubMed ID: 16470709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.